Caring Brands, Inc. (CABR)

Neutral

Insufficient data to determine institutional momentum.

Data as of Q2 2026

FY2025 basis

$1.30▼ 2.98%

EOD close · as of 2026-10-14

Market Cap

$13.5M

Enterprise Value

$11.3M

P/S

3197.8×

Revenue (FY)

$4K

Rev. growth

—

Gross margin

56%

Net margin

-148949%

ROIC

-292%

Net debt / EBITDA

—

Revenue· FY2025$4K

—

Net Income· FY2025-$6.3M

Free Cash Flow—

—

Deep analysis

Quality of the business

What backs the price

Is the profit real, and how strong is the balance sheet?

Returns on capital

ROIC -292%

-292%

✓

Pricing power

Gross margin 56%

56%

Income statement

How a revenue dollar becomes profit

FY2025 · every deduction from revenue to net income

Returns

Why ROE is -300.2%

DuPont — the three levers

Net margin

-148948.8%

profit / rev

Asset turns

0.00×

rev / assets

Leverage

1.11×

assets / year-end equity

ROE

-300.2%

on year-end equity

ROE -300% against ROIC -292% — -8% of the return on equity comes from leverage and buybacks rather than from the operating business.

Equity is the year-end figure. On average equity over the two year-ends, ROE is -217.1% — the two diverge when buybacks or issuance move equity during the year.

Leverage & liquidity

Debt structure

What the company owes vs. what it holds

Total Debt

$59K

Cash & Equivalents

$2.2M

Net Debt

-$2.1M

Net debt / EBITDA—

This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.

Operating leverage

How profit responds to sales

Latest year: profit growth vs revenue growth

Revenue Δ

—

Op. income Δ

—

Op. leverage

—

Operating leverage needs meaningful revenue change.

Operating leverage

Common-size income statement

Each line as % of revenue — the trend in color

% of revenue	FY2024	FY2025
Cost of Revenue	—	44.4
Gross Profit	—	55.6
R&D	—	0.0
SG&A	—	3504.0
Operating Income	—	-140807.2
Income Tax	—	0.0
Net Income	—	-148948.8

Green = margin-favorable vs the row's own range · red = unfavorable.

Track record · FY2024 → FY2025

How the ratios & debt developed

The metrics that matter, over time

ROE

-300%

FY2025 · latest

Net margin

-148949%

FY2025 · latest

—

ROIC

-292%

FY2025 · latest

Gross margin

56%

FY2025 · latest

—

Net debt / EBITDA

—

— · latest

—

Current ratio

13.2×

FY2025 · latest

FCF margin

—

— · latest

—

Free cash flow

—

— · latest

—

Institutional ownership: 10 holders · 2% of shares · 69th percentile crowding — Insufficient data to determine institutional momentum. (see the 13F tab)

A 30-second read on CABR: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.

Loading snapshot...

Financials

$1.30▼ 2.98%

EOD close · as of 2026-10-14

Market Cap

$13.5M

Enterprise Value

$11.3M

Revenue → Profit Flow

How a revenue dollar becomes profit — FY2025

Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.

Each value shows its share of revenue below it (common-size).

Line Item	FY2025	FY2024
Revenue	$4K 100.0%	—
Cost of Revenue	$2K 44.4%	—
Gross Profit	$2K 55.6%	—
Research & Development	$0 0.0%	$40K
Selling, General & Admin	$148K 3504.0%	—
Total Operating Expenses	$5.9M 140862.8%	—
Operating Income	-$5.9M -140807.2%	—
Interest Expense	$19K 454.7%	—
Other Income (Expense), net	-$343K -8141.5%	—
Income Tax Expense	$0 0.0%	$0
Net Income	-$6.3M -148948.8%	-$1.5M
Per Share
EPS (Basic)	-$0.46	—
EPS (Diluted)	-$0.46	—
Weighted Avg Shares (Basic)	13.6M	—
Weighted Avg Shares (Diluted)	13.6M	—

Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.

Loading financials...

Is the business good?

Can't say

No positive operating income in the last three years, so there is no return on capital to compare against its cost.

Not enough history to draw the spread — it needs at least two fiscal years with a computable ROIC and a cost of capital.

Margins need at least two fiscal years with a reported revenue and cost base.

ROE

-300%

ROIC

-292%

Gap

-8pts

Return on equity is 8 points BELOW the return on invested capital, which means the equity base is carrying capital the operations are not earning on — usually cash, goodwill, or a recent raise.

ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.

The other side

No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.

Missing from our data, so excluded from this answer: tax_rate.

Basis: FY2025Source: SEC EDGAR XBRL

Are the earnings real?

Can't say

Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.

The cash bridge needs net income and operating cash flow for the same year — one of them has no value on file here.

The other side

No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.

Missing from our data, so excluded from this answer: 3 years of cash flow.

Basis: FY2025Source: SEC EDGAR XBRL

Can it survive?

Can't say

Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.

A stress curve needs EBIT and a reported interest expense — one of them is not available for this company.

What is on hand

Cash & equivalents

$2M

excludes restricted cash

Net debt

-$2M

net cash

Current ratio

13.16×

current assets / current liabilities

Quick ratio

13.09×

excludes inventory

Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.

The other side

No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.

Missing from our data, so excluded from this answer: ebitda.

Basis: FY2025Source: SEC EDGAR XBRL

What's priced in?

Can't say

No positive free cash flow to discount, so the price cannot be expressed as a growth requirement.

Comparing the market's assumption against the record needs a solvable growth requirement and at least two years of free cash flow growth.

P / E

not reported for this company

P / S

not reported for this company

EV / EBITDA

not reported for this company

P / B

9.2× · med 3.7× · 0.86×–6.7×

CABR cohort median p25–p7514 peersvalues clipped at p1/p99 before rankingeach row scaled to its own range

The other side

No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).

Missing from our data, so excluded from this answer: free_cash_flow.

Basis: FY2025Source: SEC EDGAR XBRL

Loading analysis...

CABR vs. Perfumes, Cosmetics & Other Toilet Preparations peers

Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-06-30.

Where it ranks

top thirdmiddlebottompeer median

ValuationCheaper than peers scores higher

P / E

CABR — · med 32.1× · p25–p75 22.3×–49.8×

not enough peer data

—

P / S

CABR — · med 2.4× · p25–p75 0.6×–3.9×

not enough peer data

—

EV / EBITDA

CABR — · med 15.9× · p25–p75 12.0×–22.9×

not enough peer data

—

P / B

CABR 9.2× · med 3.7× · p25–p75 0.9×–6.7×

18th pct

GrowthLatest fiscal-year revenue vs prior year

Revenue growth (YoY)

CABR — · med 1.9% · p25–p75 -0.8%–5.5%

not enough peer data

—

ProfitabilityMargins vs the sector

Gross margin

CABR 55.6% · med 59.1% · p25–p75 44.7%–68.1%

47th pct

Operating margin

CABR — · med 14.7% · p25–p75 3.9%–17.2%

not enough peer data

—

Net margin

CABR — · med 10.1% · p25–p75 1.2%–12.1%

not enough peer data

—

FCF margin

CABR — · med 11.0% · p25–p75 5.0%–13.9%

not enough peer data

—

Returns on capitalHow hard the capital works

Return on equity

CABR -300% · med 13.7% · p25–p75 2.0%–24.6%

7th pct

Return on invested capital

CABR -292% · med 11.7% · p25–p75 1.2%–20.2%

7th pct

LeverageLess debt scores higher

Net debt / EBITDA

CABR — · med 1.6× · p25–p75 0.3×–3.5×

not enough peer data

—

13F convictionInstitutional breadth & ownership

13F holders

CABR 10 · med 807 · p25–p75 264–1,337

7th pct

Institutional ownership

CABR 1.5% · med 80.9% · p25–p75 69.1%–91.8%

8th pct

Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.

Peer table

Click a column to sort · latest FY

Company	Mkt cap ▼	P/E	EV/EBITDA	P/S	Rev gr	Gross	Net	ROE	ROIC	Net D/EBITDA	13F
PGPROCTER & GAMBLE Co	$363.6B	23.6×	17.4×	4.2×	3.3%	50.2%	18.4%	29.5%	18.1%	1.5×	3,918
ECLECOLAB INC.	$80.7B	39.5×	25.9×	5.0×	2.2%	44.5%	12.9%	21.2%	11.5%	2.2×	1,647
CLCOLGATE PALMOLIVE CO	$74.0B	35.3×	20.5×	3.6×	1.4%	60.1%	10.5%	—	26.5%	1.7×	1,958
ELESTEE LAUDER COMPANIES…	$36.8B	203.2×	23.7×	2.5×	5.0%	75.5%	1.2%	4.8%	4.2%	0.3×	807
KVUEKenvue Inc.	$34.6B	23.7×	11.8×	2.3×	-2.1%	58.1%	9.7%	13.7%	12.0%	0.1×	974
CHDCHURCH & DWIGHT CO INC…	$24.3B	34.0×	19.7×	3.9×	1.6%	44.7%	11.9%	18.4%	11.9%	1.4×	1,026
CLXCLOROX CO /DE/	$10.3B	13.0×	—	1.4×	0.2%	45.2%	11.4%	252%	28.9%	—	1,027
ELFe.l.f. Beauty, Inc.	$6.4B	245.8×	45.5×	3.9×	24.6%	70.7%	1.6%	2.3%	1.3%	3.8×	428
IPARINTERPARFUMS INC	$3.7B	21.9×	12.8×	2.5×	2.5%	63.6%	11.3%	19.1%	16.6%	0.4×	304
COTYCOTY INC.	$2.6B	—	13.6×	0.5×	-1.5%	62.9%	-10.4%	-20.2%	-10.0%	7.2×	308
SCLSTEPAN CO	$1.4B	30.3×	9.3×	0.6×	7.0%	11.6%	2.0%	3.8%	2.5%	2.4×	223
EPCEDGEWELL PERSONAL CARE…	$1.3B	53.3×	14.5×	0.6×	-1.3%	41.6%	1.1%	1.6%	0.9%	7.5×	215
ODDOddity Tech Ltd	$998M	12.0×	4.6×	1.2×	25.2%	72.7%	13.7%	27.9%	27.9%	-3.1×	138
WALDWaldencast plc	$108M	—	—	0.4×	-0.7%	67.3%	-84.4%	-49.7%	-38.4%	—	—
CABRCaring Brands, Inc.	$13M	—	—	—	—	55.6%	—	-300%	-292%	—	10

Peers = companies sharing CABR's sector (Perfumes, Cosmetics & Other Toilet Preparations) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.

Loading peer comparison...

Caring Brands, Inc. (CABR)

Deep analysis

What backs the price

How a revenue dollar becomes profit

Why ROE is -300.2%

Debt structure

How profit responds to sales

Common-size income statement

How the ratios & debt developed

Financials

Revenue → Profit Flow

Reverse DCF — what growth does the price assume?

Is the business good?

Are the earnings real?

Can it survive?

What's priced in?

Dividends & Returns

Is the payout covered?

Dividends + buybacks, per year

Debt & Leverage

Capital structure over time

Net debt / EBITDA

Debt servicing

Liquidity

Short-term vs long-term debt

CABR vs. Perfumes, Cosmetics & Other Toilet Preparations peers

Where it ranks

Peer table

Ownership Map

Buy / Sell Volume by Quarter

Institutional Trends (3 Quarters)

Institutional Holders

Institutional Holders

Dividends & Returns

Is the payout covered?

Dividends + buybacks, per year

Debt & Leverage

Capital structure over time

Net debt / EBITDA

Debt servicing

Liquidity

Short-term vs long-term debt

Buy / Sell Volume by Quarter

Deep analysis

What backs the price

How a revenue dollar becomes profit

Why ROE is -300.2%

Debt structure

How profit responds to sales

Common-size income statement

How the ratios & debt developed

Financials

Revenue → Profit Flow

Institutional Trends (3 Quarters)

Reverse DCF — what growth does the price assume?

CABR vs. Perfumes, Cosmetics & Other Toilet Preparations peers

Where it ranks

Peer table

Is the business good?

Are the earnings real?

Can it survive?

What's priced in?

Ownership Map